1 year return (CAGR)
248.17%
Century Therapeutics Inc Exchange (NASDAQ, USD)
IPSC
1.69
-0.07 (-3.98%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-8.83%
5 year return (CAGR)
-43.46%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
306.02M
Price/Sales
-
Ent value
311.04M
Price/Book
1.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-38.78%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.77 |
| Daily high | 1.77 |
| Daily low | 1.68 |
| Daily Volume | 545K |
| All-time high | 31.93 |
| 1y analyst estimate | 4.75 |
| Beta | 1.60 |
| EPS (TTM) | -0.53 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| IPSC | S&P500 | |
| Current price drop from All-time high | -94.71% | -1.38% |
| Highest price drop | -98.78% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -81.18% | -10.68% |
| Avg time to new high | 120 days | 12 days |
| Max time to new high | 1284 days | 1805 days |
News
